04/09/2013
https://congress.gov...
"the medical device review process at the Food and Drug Administration in my opinion has become overly burdensome, unpredictable and inconsistent under its current leadership."
"The issues that we are discussing today have the ability to harm our sick, inhibit innovation and stifle domestic economic jobs and growth."
"I believe we need to take steps to put privacy back into the personal realm and take it out of the consumer marketing opportunity realm."
"Thank you, Madam Chairwoman."